A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Servier
IDEAYA Biosciences
BioNTech SE
BioNTech SE
Boehringer Ingelheim
Novartis
Janssen Research & Development, LLC
7 Hills Pharma, LLC
Bristol-Myers Squibb
Parabilis Medicines, Inc.
Genmab
Novartis
Revolution Medicines, Inc.
Ipsen
Recurv Pharma Inc
Revolution Medicines, Inc.
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
Blue Earth Diagnostics
Erasca, Inc.
Eisai Inc.
GlaxoSmithKline
Alentis Therapeutics AG
Artios Pharma Ltd
Novartis
Frontier Medicines Corporation
Elicio Therapeutics
PMV Pharmaceuticals, Inc
Betta Pharmaceuticals Co., Ltd.
Akeso
Neonc Technologies, Inc.
A2 Biotherapeutics Inc.
AstraZeneca
Merus B.V.
Arvinas Inc.
Tasca Therapeutics
MBrace Therapeutics
Betta Pharmaceuticals Co., Ltd.
Revolution Medicines, Inc.
Luye Pharma Group Ltd.
GlaxoSmithKline
Syndax Pharmaceuticals
Chimeric Therapeutics
Auricula Biosciences Inc.
OneCarbon
IDEAYA Biosciences
Bold Therapeutics, Inc.
Merck Sharp & Dohme LLC
Jacobio Pharmaceuticals Co., Ltd.